The Prevalence of Simultaneously Ordering Amylase and Lipase for Diagnosing Pancreatitis.
Journal
Emergency medicine international
ISSN: 2090-2840
Titre abrégé: Emerg Med Int
Pays: Egypt
ID NLM: 101567070
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
05
2023
revised:
01
09
2023
accepted:
14
09
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
The simultaneous measurement of serum amylase and lipase levels in the diagnosis of pancreatitis was deemed unnecessary in several studies. We aim at evaluating the prevalence of the simultaneous co-ordering of serum amylase and lipase. This retrospective chart review was conducted at King Saud University Medical City in Riyadh, Saudi Arabia, between January 2021 and January 2022. We examined requests for serum amylase or serum lipase levels that had been sought for suspected pancreatitis within the electronic health system (EHS). A total of 9,617 requests for serum amylase and serum lipase levels for 5,536 patients were made in a year; 6,873 (71.5%) were made for serum lipase alone; 1,672 (17.4%) were made for co-ordered serum lipase and amylase; 322 (3.3%) were made for amylase alone; and 750 (7.8%) were made for repeated amylase testing. Four hundred and thirteen tests (4.3%) yielded a diagnosis of pancreatitis. The estimated cost reduction when serum amylase was removed if serum lipase was co-ordered was 108,680 SAR (approximately US$28,960). Serum amylase and lipase were co-ordered for about 17.4% of pancreatitis diagnostic tests, all of which were unnecessary. Eliminating serum amylase testing for any patient who receives a test of their lipase levels would exert a significant impact on institutional costs and savings.
Sections du résumé
Background
UNASSIGNED
The simultaneous measurement of serum amylase and lipase levels in the diagnosis of pancreatitis was deemed unnecessary in several studies. We aim at evaluating the prevalence of the simultaneous co-ordering of serum amylase and lipase.
Methods
UNASSIGNED
This retrospective chart review was conducted at King Saud University Medical City in Riyadh, Saudi Arabia, between January 2021 and January 2022. We examined requests for serum amylase or serum lipase levels that had been sought for suspected pancreatitis within the electronic health system (EHS).
Results
UNASSIGNED
A total of 9,617 requests for serum amylase and serum lipase levels for 5,536 patients were made in a year; 6,873 (71.5%) were made for serum lipase alone; 1,672 (17.4%) were made for co-ordered serum lipase and amylase; 322 (3.3%) were made for amylase alone; and 750 (7.8%) were made for repeated amylase testing. Four hundred and thirteen tests (4.3%) yielded a diagnosis of pancreatitis. The estimated cost reduction when serum amylase was removed if serum lipase was co-ordered was 108,680 SAR (approximately US$28,960).
Conclusion
UNASSIGNED
Serum amylase and lipase were co-ordered for about 17.4% of pancreatitis diagnostic tests, all of which were unnecessary. Eliminating serum amylase testing for any patient who receives a test of their lipase levels would exert a significant impact on institutional costs and savings.
Identifiants
pubmed: 37811499
doi: 10.1155/2023/3988278
pmc: PMC10551519
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3988278Informations de copyright
Copyright © 2023 Bader Alyahya et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Références
Gut. 2005 May;54 Suppl 3:iii1-9
pubmed: 15831893
Pancreas. 2013 Nov;42(8):1251-4
pubmed: 24152951
West J Emerg Med. 2010 Sep;11(4):344-7
pubmed: 21079706
Crit Rev Clin Lab Sci. 2012 Jan-Feb;49(1):18-31
pubmed: 22339380
Sci Rep. 2021 Jan 14;11(1):1367
pubmed: 33446814
Clin Chem Lab Med. 2002 Feb;40(2):97-100
pubmed: 11939496
Can J Surg. 2016 Apr;59(2):128-40
pubmed: 27007094
ANZ J Surg. 2001 Oct;71(10):577-82
pubmed: 11552931
Pancreatology. 2010;10(2-3):222-8
pubmed: 20484959
Am Surg. 1996 Dec;62(12):1028-33
pubmed: 8955242
Jt Comm J Qual Patient Saf. 2019 Nov;45(11):742-749
pubmed: 31523012
Indian J Clin Biochem. 2015 Apr;30(2):230-3
pubmed: 25883434
Clin Biochem. 2017 Dec;50(18):1275-1280
pubmed: 28720341
Am J Clin Pathol. 2020 Feb 8;153(3):346-352
pubmed: 31679011
BMC Gastroenterol. 2014 Aug 28;14:153
pubmed: 25168857
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
S Afr J Surg. 2014 Aug 08;52(3):72-5
pubmed: 25215951
Pancreas. 1998 Jan;16(1):45-9
pubmed: 9436862
Ann Saudi Med. 2019 Sep-Oct;39(5):354-358
pubmed: 31580713
J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):405-32
pubmed: 25973947
Pancreatology. 2010;10(5):523-35
pubmed: 20975316
ANZ J Surg. 2005 Jun;75(6):399-404
pubmed: 15943725
Ann R Coll Surg Engl. 2009 Jul;91(5):381-4
pubmed: 19409152
Am J Med Qual. 2016 May;31(3):286-7
pubmed: 26861763
BMJ Open. 2012 Sep 21;2(5):
pubmed: 23002153
Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15
pubmed: 24054878
Cleve Clin J Med. 2017 Sep;84(9):670-672
pubmed: 28885902
Gut. 1992 Jul;33(7):982-6
pubmed: 1379569